Not available in Canada: A look at COVID-19 vaccine tech from China, India and Cuba


Sumary of Not available in Canada: A look at COVID-19 vaccine tech from China, India and Cuba:

  • And some developed in India, Kazakhstan and Cuba have been in use domestically for their own populations even before completion of Phase 3 trials..
  • Vaccines of this kind have been developed by Sinovac (CoronaVac), headquartered in Shanghai China and Sinopharm (BBIBP-CorV), in Beijing, China, Bharat Biotech (Covaxin) in Hydrabad, India and The Research Institute for Biological Safety Problems (QazVac) in Zhambyl, Kazakhstan..
  • Bharat Biotch released interim Phase 3 results for its Covaxin vaccine in March and April, and the vaccine has been in use in its home country since January, when it was approved for emergency use there..
  • Similarly, the Research Institute for Biological Safety Problems rolled out its vaccine QazVac on April 23, about halfway through the completion of its Phase 3 trials..
  • None have released final results of their Phase 3 trials, but all results so far surpass the World Health Organization’s minimum of 50 per cent efficacy:.
  • People wait to receive Bharat Biotech’s COVAXIN vaccine for COVID-19 at an indoor stadium in Gauhati, India, on April 22..
  • Funk said it’s been difficult to get reliable information as the Chinese companies haven’t published their final results..
  • While officially these vaccines’ efficacy is lower, they do have an advantage — fewer side effects, especially fever….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.